Login with your work email address to view charts. No credit card required.
| Art Unit: | 1632 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
435 — Chemistry: molecular biology and microbiology 424 — Drug, bio-affecting and body treating compositions 800 — Multicellular living organisms and unmodified parts thereof and related processes 514 — Drug, bio-affecting and body treating compositions 536 — Organic compounds -- part of the class 532-570 series 600 — Surgery 426 — Food or edible material: processes, compositions, and products 425 — Plastic article or earthenware shaping or treating: apparatus |
| Phone: | (571) 272-0725 |
| Email: | valarie.bertoglio@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr (Biolgy) |
| Service: | 24 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 67% over 292 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 65th
|
With Examiner Bertoglio, you have a 67% chance of getting an issued patent by 3 years after the first office action. Examiner Bertoglio is a harder examiner and in the 65th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Bertoglio, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Bertoglio's grant rate is higher than that of Art Unit 1632 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Bertoglio | 2.2 |
| Art Unit 1632 | 2.2 |
Examiner Bertoglio has granted 131 of 213 cases without any applicant-requested interviews for a grant rate of 62%.
Examiner Bertoglio has granted 64 of 79 cases with at least one applicant-requested interview for a grant rate of 81%.
With Examiner Bertoglio, conducting an interview increases your chance of getting a patent granted by 31%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 17769182 | Ex Vivo Tumor Angiogenesis Model | Rejection information available with a Premium Stats subscription. See our pricing. | Patented | View |
| 17818623 | Viral Vectors Comprising Rdh12 Coding Regions And Methods Of Treating Retinal Dystrophies | Patented | View | |
| 18005642 | Method For Obtaining Carminic Acid | Patented | View | |
| 17806409 | Adeno-Associated Virus Compositions And Methods Of Use Thereof | Abandoned | View | |
| 18260247 | Inducer For Inducing Differentiation Of Mesenchymal Stem Cells Into Estradiol-Secreting Cells | Patented | View | |
| 18153038 | Methods For Neural Conversion Of Human Embryonic Stem Cells | Patented | View | |
| 18064821 | Methods And Compositions For Generating Hematopoietic Cells | Abandoned | View | |
| 17549105 | Composition For And Method Of Treating Hepatic Tissue Injury | Abandoned | View | |
| 19025996 | Method For Producing Induced Pluripotent Stem Cells | Patented | View | |
| 17578589 | Method For Treating Cancer | Patented | View | |
| 18418864 | Therapeutic Agents | Patented | View | |
| 17557246 | Photoreceptors And Photoreceptor Progenitors Produced From Pluripotent Stem Cells | Patented | View | |
| 17997861 | Uterine-Derived Regenerative Cell Compositions And Uses Thereof | Patented | View | |
| 17767944 | Methods Of Precise Genome Editing By In Situ Cut And Paste (Icap) | Abandoned | View | |
| 17504502 | Blood Type O Rh- Hypo-Immunogenic Cells | Patented | View | |
| 18318668 | Umbilical Cord-Derived Adherent Stem Cells, Preparation Method Therefor, And Use Thereof | Patented | View | |
| 17094855 | Chimeric Antigen Receptor Specific For Tumor Cells | Abandoned | View | |
| 18515879 | Method For Reducing Immunogenicity Of Rna | Patented | View | |
| 16969045 | Composition For Promoting Efficiency Of Somatic Cell Replication | Patented | View | |
| 18999456 | Targeting The Pvr Axis Using Car T Cell Therapy And Combinations | Patented | View | |
| 17906145 | Ready-To-Use Fly Neonate Larvae With Extended Shelf-Life And Methods Of Producing Same | Patented | View | |
| 18081476 | Retinal Pigment Epithelium Cell Compositions | Abandoned | View | |
| 16663649 | Transgene-Cytotoxic Combination Therapy | Abandoned | View | |
| 18442444 | Non-Human Animals Expressing Humanized Cd3 Complex | Patented | View | |
| 17666334 | Method Of Generating Hepatic Cells | Patented | View | |
| 16896261 | Methods For Treating Radiation Or Chemical Injury | Abandoned | View | |
| 17886067 | Systems And Methods For Cell Culturing | Patented | View | |
| 17932915 | Crispr-Cas10 Systems And Methods For Phage Genome Editing | Patented | View | |
| 17241651 | Use Of Rna For Reprogramming Somatic Cells | Patented | View | |
| 18156205 | Assay For Drug Discovery Based On In Vitro Differentiated Cells | Abandoned | View | |
| 18064441 | Agent For Accelerating Growth Of Pluripotent Stem Cells | Patented | View | |
| 17622364 | Method Of Preparing Mouse Model Of Herpes | Patented | View | |
| 17439184 | Modified Adenovirus And Medicine Comprising Same | Patented | View | |
| 18187268 | Transduced T Cells Expressing Human Sstr2 And Application Thereof | Patented | View | |
| 18541448 | Generation Of Alveolar Epithelial Type 1 (At1) Cells | Patented | View | |
| 17673453 | Rna Engineered T Cells For The Treatment Of Cancer | Abandoned | View | |
| 16972118 | Pharmaceutical Composition Comprising Mesenchymal Stem Cells As Effective Ingredient For Prevention Or Treatment Of Inflammatory Disease | Patented | View | |
| 16963880 | Expression Vector And Method | Patented | View | |
| 17059059 | Car Nk Cells | Patented | View | |
| 17671312 | In Vitro Proliferation Medium, In Vitro Culture Kit And In Vitro Proliferation Culture Method Of Umbilical Cord Blood (Ucb)-Derived Natural Killer (Nk) Cells | Abandoned | View | |
| 16966521 | Transcription Regulatory Elements And Uses Thereof | Patented | View | |
| 17557525 | Tissue-Derived Tissuegenic Implants, And Methods Of Fabricating And Using Same | Abandoned | View | |
| 17427449 | Use Of Mouse Model In Evaluation Of Intelligence Level | Patented | View | |
| 17254725 | Optimized Cln5 Genes And Expression Cassettes And Their Use | Patented | View | |
| 17511092 | Methods And Compositions For Monitoring And Enhancing Early Embryo Development | Abandoned | View | |
| 16928774 | Cell Culture Device And Cell Culture Method | Abandoned | View | |
| 18904578 | Absolute Precipitation Of Exosomes (Apex) Isolation | Patented | View | |
| 18735079 | Method For Analyzing Content And Distribution Of Microplastics In Marine Cnidaria Organisms | Patented | View | |
| 18316688 | Recombinant Constructs And Transgenic Fluorescent Ornamental Fish Therefrom | Patented | View | |
| 17416044 | Embryonic Erythroblast-Containing Cell Population And Method For Producing Same, Cell Culture Composition, And Compound Test Method | Patented | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.